Skip to main content


  • Correction
  • Open Access

Correction to: CART cells are prone to Fas- and DR5-mediated cell death

  • 1,
  • 1,
  • 1,
  • 1,
  • 2, 3,
  • 2, 3,
  • 4,
  • 4,
  • 2, 3,
  • 1 and
  • 1Email author
Journal for ImmunoTherapy of Cancer20186:92

  • Received: 14 September 2018
  • Accepted: 14 September 2018
  • Published:

The original article was published in Journal for ImmunoTherapy of Cancer 2018 6:71


After publication of this article [1], it was noticed that 3 authors were missed from the author list. These authors are Evripidis Lanitis, Melita Irving and George Coukos. The correct author list can be seen above and updated Competing Interests, Authors’ Contributions and Acknowledgements can be seen below.




We are grateful to P. Reichenbach for sharing his expertise in DNA cloning strategies. Special thanks to Prof. M. Thome for sharing her expertise in the field of T cell signalling.

Authors’ contributions

AD and BT designed and developed the study. BT, ND, BM and LZ performed the experiments, acquired and analyzed the data. E.L. has set up the protocol of transduction of murine primary lymphocytes. EL, MI and GC contributed to the conception, experimental design and analysis of results. PS shared his expertise on programmed cell death and provided essential reagents. AD, BT, LZ, PR and JPM wrote the manuscript. All authors read and approved the final manuscript.

Competing interests

All co-authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

Department of Fundamental Oncology, Translational Tumor Immunology Group, Lausanne, Switzerland
Department of Oncology, University Hospital of Lausanne, Lausanne, Switzerland
Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland
Department of Biochemistry, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland


  1. Tschumi BO, Dumauthioz N, Marti B, Zhang L, Schneider P, Mach J-P, et al. CART cells are prone to Fas- and DR5-mediated cell death. J Immuno Cancer. 2018;6:71 ArticleGoogle Scholar


© The Author(s). 2018